Skip Navigation LinksHome > May 2013 - Volume 21 - Issue 3 > Does Antibiotic De-escalation for Nosocomial Pneumonia Impac...
Infectious Diseases in Clinical Practice:
doi: 10.1097/IPC.0b013e318279ee87
Original Articles

Does Antibiotic De-escalation for Nosocomial Pneumonia Impact Intensive Care Unit Length of Stay?

Knaak, Elizabeth PharmD*; Cavalieri, Stephen J. PhD; Elsasser, Gary N. PharmD*†; Preheim, Laurel C. MD; Gonitzke, Alyssa PharmD*; Destache, Christopher J. PharmD*†

Collapse Box

Abstract

Background: Hospital-acquired pneumonia (HAP), ventilator-associated pneumonia (VAP), and health care–associated pneumonia (HCAP) are associated with substantial morbidity, mortality, and costs in the intensive care unit (ICU). The impact of antibiotic de-escalation on resource utilization, namely, length of stay (LOS) and cost of hospitalization, was investigated.

Methods: A retrospective chart review was conducted from ICU admission of adult patients with a presumptive diagnosis of HAP, VAP, or HCAP in the 2009–2010 year. American Thoracic Society/Infectious Disease Society of America definitions for HAP, VAP, or HCAP were used. Eligible patients had blood and/or respiratory cultures collected before institution of empiric antibiotics. De-escalation required discontinuation of one or more empiric agent or change to narrower-spectrum antibiotic. The primary end point was the effect of antibiotic de-escalation on ICU LOS.

Results: One hundred thirteen patients, representing 117 cases of HCAP, HAP, and VAP, met eligibility criteria. De-escalation was performed in 73 (62%) of pneumonias. De-escalated patients were more likely to be older (65.1 [SD, 16.8] vs 57.6 [SD, 19] years, P < 0.05) and have cardiovascular disease (37% vs 14%, P < 0.01). Intensive care unit LOS (9.3 [SD, 11.6] vs 13 [SD, 9.7] days, P = 0.069) was not significantly different; however, a significant difference in hospitalization costs ($38,016 [SD, 43,010] vs $55,217 [SD, 47,642], P < 0.05) was found between the 2 groups. In-hospital mortality was significantly lower in de-escalated pneumonias (15% vs 39%, P < 0.01).

Conclusions: Although ICU LOS was not significantly different in this study, de-escalation was associated with significant reduction in resource utilization. In ICU patients with HCAP, HAP, or VAP, de-escalation affords an opportunity to improve antimicrobial stewardship and decrease resource utilization at no detriment to clinical outcome.

© 2013 by Lippincott Williams & Wilkins.

Article Tools

Share

Article Level Metrics

Search for Similar Articles
You may search for similar articles that contain these same keywords or you may modify the keyword list to augment your search.